{"status": "ok", "totalResults": 7, "articles": [{"source": {"id": "the-verge", "name": "The Verge"}, "author": "Jess Weatherbed", "title": "Attendees experience \u2018severe eye burn\u2019 following Bored Ape NFT event - The Verge", "description": "Several people have reported experiencing eye pain, vision problems, and sunburnt skin on Sunday after attending ApeFest, a Bored Ape Yacht Club NFT collection event in Hong Kong.", "url": "https://www.theverge.com/2023/11/6/23948464/bored-ape-nft-event-eye-injury-sunburn-uv-exposure", "urlToImage": "https://cdn.vox-cdn.com/thumbor/9x4hNOxXGWC014_lqWyAgSZDoHY=/0x0:1920x1300/1200x628/filters:focal(967x1033:968x1034)/cdn.vox-cdn.com/uploads/chorus_asset/file/25061592/ApeFest_2023.jpg", "publishedAt": "2023-11-06T12:35:33Z", "content": "Bored Ape NFT event attendees report severe eye burn\r\nBored Ape NFT event attendees report severe eye burn\r\n / Yuga Labs says its currently investigating reports of impeded vision and skin/eye injuri\u2026 [+2131 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": "Julia Payne", "title": "EU proposal may accelerate pharma innovation decline, industry group says - Reuters", "description": "A <a href=\"/business/healthcare-pharmaceuticals/after-covid-drug-shortages-eu-revamps-drug-laws-2023-04-03/\">major pharmaceutical rules overhaul</a>, proposed by the European Commission in April, could see Europe's share in global research and development con\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/eu-proposal-may-accelerate-pharma-innovation-decline-industry-group-says-2023-11-06/", "urlToImage": "https://www.reuters.com/resizer/Yaeu8fdL8PJ72sTlfgBbDpMKdCY=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/XAZQHFBWRRL2FBT5PU2SNIH5PM.jpg", "publishedAt": "2023-11-06T09:55:00Z", "content": "BRUSSELS, Nov 6 (Reuters) - A major pharmaceutical rules overhaul, proposed by the European Commission in April, could see Europe's share in global research and development contract by a third to 21%\u2026 [+2751 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": "Elvira Pollina", "title": "Telecom Italia approves KKR's $20 billion grid bid in blow for Vivendi - Reuters", "description": "Telecom Italia (TIM) <a href=\"https://www.reuters.com/markets/companies/TLIT.MI\" target=\"_blank\">(TLIT.MI)</a> on Sunday approved the 19 billion euro ($20 billion) sale of its fixed-line network to U.S. private equity firm KKR <a href=\"https://www.reuters.com\u2026", "url": "https://www.reuters.com/markets/deals/telecom-italia-gives-green-light-kkrs-grid-bid-sources-say-2023-11-05/", "urlToImage": "https://www.reuters.com/resizer/JrByiJ9jqQnZUeo1UpOHcEeeQ8U=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/XIVARIGIKNPENGCBR4OQHYHDW4.jpg", "publishedAt": "2023-11-06T09:43:00Z", "content": "MILAN, Nov 6 (Reuters) - Telecom Italia (TIM) (TLIT.MI) on Sunday approved the 19 billion euro ($20 billion) sale of its fixed-line network to U.S. private equity firm KKR (KKR.N), becoming the first\u2026 [+3205 chars]"}, {"source": {"id": "ars-technica", "name": "Ars Technica"}, "author": "Steven Ewing", "title": "Driving the Volvo EX30, a $36K EV that prioritizes sustainability - Ars Technica", "description": "Volvo says the EX30's carbon footprint is 25 percent smaller than the C40 or XC40.", "url": "https://arstechnica.com/cars/2023/11/driving-the-volvo-ex30-a-36k-ev-that-prioritizes-sustainability/", "urlToImage": "https://cdn.arstechnica.net/wp-content/uploads/2023/11/Volvo_EX30_CloudBlue_98-760x380.jpg", "publishedAt": "2023-11-06T08:00:55Z", "content": "Enlarge/ There are growing calls for smaller, cheaper electric vehicles, and at least Volvo has been listening.\r\n103 with \r\nVolvo provided flights from Los Angeles to Barcelona and three nights in a \u2026 [+6557 chars]"}, {"source": {"id": "financial-times", "name": "Financial Times"}, "author": "Harriet Agnew", "title": "Ken Griffin warns against hedge fund clampdown - Financial Times", "description": "Plus, Goldman\u2019s big growth bet, private equity\u2019s reckoning, and Vincent van Gogh\u2019s final weeks", "url": "https://www.ft.com/content/e01f5cec-ca45-4f35-bec4-92356162497a", "urlToImage": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fwww.ft.com%2F__origami%2Fservice%2Fimage%2Fv2%2Fimages%2Fraw%2Fhttps%253A%252F%252Fd1e00ek4ebabms.cloudfront.net%252Fproduction%252Fa44b2ec3-eec4-4047-8966-cf3486cc9100.png%3Fsource%3Dnext-article%26fit%3Dscale-down%26quality%3Dhighest%26width%3D700%26dpr%3D1?source=next-opengraph&fit=scale-down&width=900", "publishedAt": "2023-11-06T06:00:29Z", "content": "Welcome to FT Asset Management, our weekly newsletter on the movers and shakers behind a multitrillion-dollar global industry. This article is an on-site version of the newsletter. Sign up here to ge\u2026 [+11095 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Laura Benitez, Silas Brown", "title": "Private Credit: Apollo, Ares, Tikehau Face Limits On Who They Can Buy From - Bloomberg", "description": "PE-style \u201cwhitelists\u201d hamper efforts to expand the secondary market for fund stakes, as regulators raise liquidity concerns about private capital.", "url": "https://www.bloomberg.com/news/articles/2023-11-06/private-credit-apollo-ares-tikehau-facing-limits-on-who-they-can-buy-from", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iwxN6YhqArAs/v0/1200x800.jpg", "publishedAt": "2023-11-06T05:02:06Z", "content": "Attempts by some of private credits biggest names to develop a hot new corner of the $1.6 trillion market have hit a roadblock: their peers.\r\nBuyers including Apollo Global Management, Ares Managemen\u2026 [+312 chars]"}, {"source": {"id": "financial-times", "name": "Financial Times"}, "author": "Andy Bounds", "title": "Novo Nordisk warns EU that new rules will push it to expand faster in US - Financial Times", "description": "Drugmakers claim that Brussels\u2019 market exclusivity overhaul will reduce R&D investment", "url": "https://www.ft.com/content/add3a6b5-3519-4c9a-8ad8-12e091a5ddee", "urlToImage": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fwww.ft.com%2F__origami%2Fservice%2Fimage%2Fv2%2Fimages%2Fraw%2Fhttps%253A%252F%252Fd1e00ek4ebabms.cloudfront.net%252Fproduction%252F905014ee-ce74-4306-b9dd-e0628d2045f4.jpg%3Fsource%3Dnext-article%26fit%3Dscale-down%26quality%3Dhighest%26width%3D700%26dpr%3D1?source=next-opengraph&fit=scale-down&width=900", "publishedAt": "2023-11-05T23:01:56Z", "content": "Novo Nordisk, Europes most valuable drugmaker, will accelerate its US expansion at the expense of the EU unless Brussels changes a plan to reform regulation of the industry, the companys chief execut\u2026 [+3390 chars]"}]}